Pharmacy Management

Pharmacy Board Malaysia 2009 1
CODE OF CONDUCT FOR PHARMACISTS AND BODIES

CORPORATE
by
PHARMACY BOARD MALAYSIA

PART ONE: INTRODUCTION
1. PREAMBLE

In the pharmacy profession, the health and welfare of
the public has always been and will continue to be
the foremost concern among pharmacists. For this
principle to be consistently placed above all other
considerations in the practice of pharmacy, this Code
of Conduct for Pharmacists and Bodies Corporate
has embodied the minimum standards of proper
conduct and professionalism for guidance of
pharmacists. These standards also serve as a
reference when the Board considers cases of
misconduct in a professional sense.
2. USE OF TERMS

For the purpose of this Code of Conduct-
"Act" means the Registration of Pharmacists Act
1951;
"allied profession" means any profession involved in
the provision of health care to, or treatment of
diseases or conditions of, man or animals;


"annual certificate" means an annual certificate
issued under section 16 of the Act;
"the Board" means the Pharmacy Board established
under section 3 of the Act;
"body corporate" means a body corporate whose
name appears for the time being in the register kept
under section 13 of the Act;
"the Code" means the Code of Conduct for
pharmacists and bodies corporate;
"dangerous drug" has the meaning assigned to it in
the Dangerous Drugs Act 1952;
"drug" has the meaning assigned to it in the Sale of
Drugs Act, 1952;
"pharmacist" means a registered pharmacist in the
Act;
"poison" has the meaning assigned to it in the
Poisons Act 1952;
"register" used with reference to a pharmacist or a
body corporate means the register under the
provisions of the Act applicable to the registration of
pharmacists or bodies corporate respectively;
"the Regulations" means the Registration of
Pharmacists Regulations 2004;
"superintendent" means the superintendent of a body
corporate described under section 13 of the Act.

3. STATEMENT ON INFAMOUS OR DISGRACEFUL
CONDUCT IN A PROFESSIONAL SENSE AND
MISCONDUCT

For the purpose of Section 17 (1) (c) of the Act, any
pharmacist found guilty of any breach of the Code by
the Board after due inquiry under the Regulations,
shall be deemed to be in the opinion of the Board,
guilty of infamous or disgraceful conduct in a
professional sense, and shall be liable to such
disciplinary action by the Board as the Board deems
fit under the provisions of the Act.
Similarly, for the purpose of Section 13 (7) (b) (iii) of
the Act, any director, or officer of or other person in
the employment of any body corporate found guilty
by the Board of any breach of the Code, shall be
deemed to be in the opinion of the Board, guilty of
misconduct and such body corporate shall be liable
to such disciplinary action by the Board as the Board
deems fit under the provisions of the Act.


PART TWO: CODE OF CONDUCT

It must already be understood that the particulars
which are given below do not constitute, and are not
intended to constitute a complete enumeration of the
professional matters, the breach of which may entail
disciplinary proceedings by the Board. It does not in
any way preclude the Board from considering and
dealing with any form of infamous and disgraceful
conduct in a professional sense and misconduct,
although the subject matter may not appear to come
within the scope or precise wording of any of the
categories set forth in this Code. Circumstances may
and do arise from time to time in relation to which
there may occur questions on conduct which do not
come within these categories. In such instances as in
all others, the Board shall be considered the judge
upon the facts brought before it.
ARTICLE 1: PROFESSIONAL RESPONSIBILITY

1.1 Responsibility for Standards of
Professional Practice
1.1.1 A pharmacist when providing any
professional service or intervention must do so on
the basis of accurate and current information for
which they are qualified in their area of competence
and within their scope of practice. The pharmacist
shall maintain the highest professional standard in
the discharge of his professional service to his
patients or clients.

The Professional Standards Are:
(a) Health and Safety of Patient or Clients
(i) Pharmacists must have specialized
knowledge about medicines, health
related products, medicinal and
complimentary therapies and are expected
to use this knowledge to benefit their
patients or clients.
(ii) Pharmacists are aware of the limitations of
their knowledge and skills and refer
patients to appropriate health care
professionals when they are unable to
meet the needs of their patients or clients.
(iii) Pharmacists supply only prescription and
nonprescription medicines and health
related products that are safe, effective
and of good quality.

(b) Professional Relationship With Patient or
Clients
(i) Pharmacists respect the professional
relationship with the patient or clients and
act with honesty, integrity and compassion.
(ii) Pharmacists determine the patient needs,
values and desired outcomes.
(iii) Pharmacists seek to involve their patients
or clients in the decisions regarding their
health.


(c) Autonomy, Values and Dignity of Patient or
Clients
(i) Pharmacists provide their patients or
clients with information that is truthful,
accurate and understandable so that the
patients or clients are able to make
informed choices about health care.
(ii) Pharmacists are committed to each patient
or client regardless of race, religion,
gender, sexual orientation, age or health.
(iii) Pharmacists respect the informed
decisions of competent patients or clients
who choose to refuse treatment/services
and live at risk.
(iv) Pharmacists respect the dignity of patients
or clients with diminished competence and
seek to involve them, to an appropriate
extent, in decisions regarding their health.
(v) It should be noted these provisions should
apply to any advice given with regards to
any medicine, complementary therapy or
other healthcare product provided by any
means whatsoever, including the internet
and other electronic media.

(d) Respect and Protect the Patients or Clients
Right of Confidentiality
(i) Pharmacists keep confidential all
information acquired in the course of
professional practice.
(ii) Pharmacists may disclose prescription
information for ethical reasons (e.g.
scientific research) only if the information
will not identify the patient or client.

(iii) Confidential information is disclosed only
in cases where the patient or client (or the
patients or clients agent) provides
consent, where the law demands or where
disclosure will protect the patient or clients
or others from harm.

(e) Respect the Rights of Patients or Clients to
Receive Pharmacy Services
(i) Pharmacists who are unable to provide
prescribed medicines or services to their
patients or clients shall take reasonable
steps to ensure these medicines or
services are provided and the patients or
clients care is not jeopardized.
(ii) Pharmacists who are unwilling to provide
prescribed medicines or services to
patients or clients because of moral or
religious reasons shall inform pharmacy
management of their objections at the
onset of employment. Pharmacy
management shall provide reasonable
accommodation of the pharmacists right of
conscience and develop an alternate
means of providing the medicines or
services. The alternate means shall be
timely and convenient for the patient or
client.
(iii) Pharmacists have a duty, through
communication and co-ordination, to
ensure the continuity of care of patients or
clients during pharmacy relocation or
closure, job action, natural disasters or
situations where continuity of care may be
problematic.

1.1.2 A pharmacist shall maintain the highest
professional standard in his conduct, and in his
professional relations with members of his own
profession and other allied professions.

(a) Pharmacists obey the laws, regulations,
standards and policies of the profession both in
letter and in spirit.
(b) Pharmacists do not condone breaches of the
law, regulations, standards or policies by
colleagues, co-workers or owners of a pharmacy
and report, without fear, such breaches.
(c) Pharmacists accept the ethical principles of the
profession and do not engage in activity that will
bring discredit to the profession.
(d) Pharmacists do not abuse drugs or alcohol, do
not condone the abuse of drugs or alcohol by
colleagues or co-workers and report, without
fear, such abuse.
(e) Pharmacists do not practice under conditions
which compromise their freedom to exercise
professional judgment or which cause a
deterioration of the quality of their professional
service or care.
(f) Pharmacists do not seek more than fair and
reasonable remuneration for their professional
services.
(g) Pharmacists do not enter into arrangements with
prescribers that could affect the prescribers
independent professional judgments in
prescribing or that could interfere with the
patients right of choice of a pharmacy.


(h) Pharmacists do not accept inducements from
suppliers that could reasonably be perceived as
affecting the pharmacists independent
professional judgment.
(i) Pharmacists advertise and promote themselves
only via methods which uphold the dignity and
honour of the profession and which are within
the boundaries of the existing legislation.
1.1.3 Relationship with Pharmacists and members
of the allied profession.

(a) Pharmacists respect the values and abilities of
colleagues and other health care professionals.
(b) Keeping confidentiality in mind, pharmacists
consult with colleagues or other health care
professionals to benefit the patient. If
appropriate, pharmacists refer their patients to
other health care professionals or agencies.
(c) Pharmacists maintain professional relationships
with colleagues and ensure patients needs are
met when supplying colleagues with transfer
copies of prescriptions, inventory, etc.

1.1.4 A Pharmacist must neither agree to practice
under conditions which may compromise their
professional independence, judgment or integrity, nor
impose such conditions on other pharmacists.

(a) A pharmacist must freely exercise professional
judgment when carrying out the duties of a
pharmacist and should not accept employment
in which this freedom may be compromised.


(b) A pharmacist managing an environment in
which other pharmacists are employed must
ensure the professional autonomy of those
pharmacists is preserved.
(c) A pharmacist must avoid situations likely to
present a conflict of interest or compromise the
objectivity of their professional practice.
1.2 Professional Development and Contributions
To Society
1.2.1 Pharmacists should continuously improve
their levels of professional knowledge and skills by
continually evaluating and improving their
professional competence.
1.2.2 Pharmacists participate in the enhancement
of the profession of pharmacy.

(a) Pharmacists associate with organisations that
strive to improve the profession of pharmacy.
(b) Pharmacists contribute to the future of the
profession by participating, willingly and
diligently, in the education of students and
candidates for registration.
(c) A pharmacist must endeavour to foster the
future development of the profession by
encouraging and mentoring students, pre-
registrants and newly registered pharmacists in
their professional development. He shall be a
willing, sincere as well as diligent preceptor and
be seen as a role model. He should
demonstrate to them that competence and
character are inseparable for a professional.
The new graduates are expected to acquire the
character traits and professional values that are
inherent to the profession.

1.2.3 Pharmacists contribute to the health care
system and to societal health needs.

(a) Pharmacists support positive changes in the
health care system by actively influencing and
participating in health policy development,
review and revision.
(b) Pharmacists support cost-effective therapies.
(c) Pharmacists support the prudent use of health
care resources.
(d) Pharmacists participate in programs to educate
the public about health.
(e) Pharmacists foster the advancement of
knowledge by supporting appropriate research
projects, wherever possible.
(f) Pharmacists support environmental issues
related to pharmacy by promoting the safe
disposal of drugs and related products.
(g) In the provision of consultation or professional
advice, a pharmacist shall, with due regard to
the interest of the patient or client, strive to
provide such information that is truthful, accurate
and without bias.
1.2.4 Notification of the availability of 24 hour
pharmacy services may be on doorplate pertaining to
practicing hours of the pharmacist or on the existing
pharmacy signboard. Registered pharmacists having
valid licence should be available at all times and his
availability should be within a reasonable period of
time not exceeding 30 min.
1.2.5 In the event that an emergency arises, the
pharmacist may informed patients or clients by
means of notice of his availability.

1.3 Relationship With Other Pharmacists and
Members of The Allied Profession
1.3.1 In his practice, a pharmacist shall not by words
or deed or by inference thereof discredit or disparage
the professional integrity, or judgment, or skill of
another pharmacist or of a member of an allied
profession.
1.3.2 In dispensing a prescription, a pharmacist
shall not attempt to secure for himself the care of the
patient whose prescription had been dispensed.
1.3.3 In conformity with his own sense of
responsibility, a pharmacist shall refer a patient or
client to members of other allied professions when, in
the opinion of the pharmacist, the interest of the
patient or client, is better served by members of that
profession.
1.4 Dispensing
When any doubt arises in the interpretation of a
prescription accepted by a pharmacist, he shall
consult the prescriber and shall not alter the
prescription unless with the approval of the
prescriber or in an emergency.
The therapeutic efficacy of prescriptions shall not be
discussed with patient or others in such a manner as
to impair confidence in the prescriber.
A pharmacist who has accepted a prescription for
dispensing, shall dispense the prescription exactly in
accordance with the prescribers wishes. A
pharmacist must not (except with the approval of the
prescriber, or in an emergency) substitute any
product for a specifically named product, even if the

therapeutic effect and quality of both product are
identical.
Where there are errors in dosage or potential drug
interactions, the pharmacist must inform the
prescriber immediately in a discreet manner, so as
not to alarm the patient.
1.5 Delegation of Duties
1.5.1 Employment of Unqualified or Non- registered
Persons

The employment by pharmacists or Body Corporate
of any person not qualified or registered under the
Act, and the permitting of such unqualified or non-
registered person to perform any task, which would
otherwise require the supervision of a pharmacist, or
which requires the professional discretion or skill of a
pharmacist, is in the opinion of the Board in its nature
fraudulent and dangerous. All pharmacists are
required to abstain from such fraudulent and
dangerous practice.

1.5.2 Supervision and Responsibility
In the event where persons other than pharmacists
are required to perform any act which requires the
supervision of a pharmacist, the pharmacist shall be
available for immediate consultation and in full control
of the person and the act performed.

The pharmacist shall ensure that the supporting staff
to whom tasks are delegated, have the competencies
necessary for the efficient and effective undertaking
of these tasks and that all information provided to
patients, other members of the public and other
health professionals is accurate and given in a

manner designed to ensure that it is understood.
Pharmacist shall not delegate responsibility requiring
professional judgment except to another registered
pharmacist.

1.6 Pharmaceutical Research
In the scientific application of pharmaceutical
research carried out on human beings it is the duty of
the pharmacist to uphold the sanctity of human life.
1.6.1 A pharmacist shall not be a party to any
research on human beings unless the research
proposal has been approved by the appropriate
ethics committee.
(a) each potential subject has been adequately
informed of the aims, methods, anticipated
benefits and potential hazards of the study and
the discomfort it may entail;
(b) the subject has been informed that he is at
liberty to abstain from participation in the study
and that he is free to withdraw his consent to
participate at any time;
(c) the subject of his own free will, has given written
consent to participate in the study.
1.6.2 The pharmacist can combine scientific
research with professional care, the objective being
the acquisition of new knowledge, only to the extend
that the research is justified by its potential value for
the patient.
1.6.3 A pharmacist shall use great caution in
divulging discoveries through non-professional
channels.


1.6.4 The results of any research on human subjects
should not be suppressed whether adverse or
favourable.

1.7 Continuing Education

A pharmacist shall strive to keep abreast of new
knowledge and advancement relevant to his practice
by actively engaging himself in continuous study
throughout his professional life in order to merit the
confidence in his professional competence.
1.8 Relationship with the Pharmaceutical
Industry
The pharmacist and the pharmaceutical industry
have a common interest in the promotion and care of
the health of the public. Although the closest co-
operation between the pharmacist and the
pharmaceutical industry is encouraged:
1.8.1 A pharmacist shall avoid a situation, whereby
he, by accepting any financial or material
inducement, would compromise his professional
judgement on the choice of drug for his patient or
client.
1.8.2 A pharmacist shall not participate in the
promotion of a drug which involves the supply of such
drug without discrimination to his patient or client or
which by-passes his professional function.
1.8.3 To sustain public confidence in the profession,
a pharmacist shall not only choose but also be seen
to be choosing the drug which, in his professional
judgement and having due regard to economy and
rational drug use, will best serve the interest of his
patient or client.

ARTICLE 2: ABUSE OF PROFESSIONAL PRIVILEGES AND
SKILLS

2.1 Abuse of Privileges Conferred by Law
The law confers upon the pharmacist certain
privileges pertaining to the sale, supply, import,
export, manufacture and generally dealing in drugs.
The transactions in such drugs are subjected to
statutory control.
2.1.1 Sale of Drugs and Medical Devices
The sale or supply of medical devices and drugs
including drugs of dependence shall only be made in
the course of bona fide treatment. No drugs should
be sold or supplied in order to gratify the pharmacist's
own or any other person's gratification.
A pharmacist shall not sell or supply any drug or
medical device where he has any reason to doubt its
safety, quality or its therapeutic value, and shall not
condone or assist in the dispensing promotion, or
distribution of such drugs or devices. It is unethical
for a pharmacist to sell or supply any unregistered
product unless with approval.
A pharmacist shall take into due consideration the
needs and welfare of his patient or client and shall
not sell or supply drugs, medical devices or health
products which are unnecessary or likely to be
misused or abused or in such amounts which are
excessive.
A pharmacist who solicits patients or clients to
purchase drugs, medical devices or health products
commits a discreditable act.

2.1.2 Dangerous Drugs
All pharmacists shall abstain from abusing the
privileges conferred upon them under the Dangerous
Drugs Act 1952 and the Regulations made
thereunder.
2.1.3 Sale of Poisons and Psychotropic Substances
It is professionally discreditable and fraught with
danger to the public when a pharmacist or body
corporate employs an unqualified person who is left
in charge of a shop selling or supplying poisons,
under the cover of the qualifications of such
pharmacist or any other pharmacist employed by
such pharmacist or body corporate. No pharmacist or
body corporate shall take part in whether by act or
omission, or be a party to such discreditable and
dangerous practice.
In the sale or supply of poisons, a pharmacist shall
take reasonable precautions and measures to
ascertain that such poisons sold or supplied are in
fact sold or supplied and delivered to bone fide
authorised person and for authorised purposes.
In the sale, supply or dealing with psychotropic
substances, a pharmacist shall abstain from abusing
the privileges conferred to them under the Poisons
(Psychotropics Substances) Regulations 1989. The
pharmacist shall comply with the storage and records
of transactions pertaining to psychotropic substances
under the regulations.


2.1.4 Accountability
It is a privilege for a pharmacist to be a legal
custodian of poisons, psychotropic substances and
dangerous drugs. By conferring this privilege upon
him, not only is he held accountable for such
substances as required by law, but, from a moral and
ethical point of view, he is expected to exercise
professional accountability,
Concurrent with this, the Board is also of the opinion
that a body corporate is equally bound to exercise the
same degree of accountability as required of a
pharmacist. This responsibility is trusted upon a body
corporate in return for permitting it to carry on a
business of keeping, retailing, dispensing and
compounding of poisons, dangerous drugs and
therapeutic substances.
2.1.5 Covering
A pharmacist shall not allow any other person to use
his licence to cover any dealing in poisons,
psychotropic substances or dangerous drugs. All
transaction of poisons, psychotropic substances and
dangerous drugs shall be bona fide conducted by the
pharmacist or under his immediate personal
supervision as provided under the existing legislation.
2.1.6 Certificates and Documents of a Kindred
Character
Pharmacists may from time to time be called upon or
requested to give certificates and other documents of
a kindred character, signed by them in their practice
for administrative purposes.

Pharmacists are expected to exercise the most
scrupulous care in issuing such documents
and shall not sign or give under his name and
authority any such certificate or document
which is untrue, misleading or improper.
2.2 Abuse of Privileges Conferred by Custom
A good professional practice depends upon the
maintenance of trust between pharmacists and their
patients or clients, and the understanding of both
parties that proper professional relationship be strictly
observed. The pharmacist shall exercise great care
and discretion in order not to injure this crucial
relationship.
2.2.1 Abuse of Confidence
A pharmacist shall not improperly disclose
information which he obtains in confidence from or
about a patient or client unless there is a legal need
of the disclosure.
2.2.2 Undue Influence
A pharmacist may not exert improper influence upon
a patient to receive any monetary, return or benefit.
ARTICLE 3: CONDUCT DEROGATORY TO THE
REPUTATION OF THE PROFESSION

3.1 Respect for Human Life
The utmost respect for human life should be
maintained even under threat, and no use should be
made of any professional knowledge contrary to the
laws of humanity.

3.2 Personal Behaviour
A pharmacist is expected at all times to observe
proper standards of personal behaviour and decency
not only in his Professional activities but at all times
to uphold the high public reputation of the profession.
3.2.1 Personal Misuse of Alcohol or Drugs
A pharmacist who performs any professional duty
while in a state of intoxication by alcohol or under the
influence of drugs commits a discreditable act. No
pharmacist shall practice in such a state. Drug abuse
by a pharmacist is professionally discreditable.
3.2.2 Dishonesty.
A pharmacist shall be liable to disciplinary
proceedings if he is convicted of criminal deception,
forgery, fraud, theft or of any other offence involving
dishonesty.
A pharmacist shall not sell or supply with prior
knowledge any drug or medical device which is
defective or is incapable of serving the purpose it is
intended for or is falsely or fraudulently labelled or
presented.
A pharmacist shall not act for improper motives. A
pharmacist's motive is considered improper if he sells
or supplies any drug or medical device purely for his
financial or material benefit, or if such act is
motivated by his acceptance of an improper
inducement from the supplier of the drug or medical
device.
Fee-splitting or any form of kick back arrangements
as an inducement to refer patients or clients to other

members of the allied profession may be regarded as
unethical. A pharmacist shall not recommend a
particular member of the allied profession or a
medical practice unless so requested by his patient
or client seeking medical advice.
3.2.3 Indecency and Violence
Any conviction for assault or indecency is derogatory
to the dignity of the profession and thus regarded as
a serious breach of conduct and will be viewed with
particular gravity if the offence is committed in the
course of a pharmacist's professional duties or
against his patients or colleagues.
3.3 Conflict of Interest
The pharmacist shall avoid any situation in which
there is a conflict of interest with the patient.
ARTICLE 4: ADVERTISING CANVASSING AND RELATED
PROFESSIONAL OFFENCES

The practice by a pharmacist of advertising, whether
directly or indirectly, for the purpose of promoting his
own professional advantage; or for such purpose of
procuring or sanctioning, or acquiescing in, the
publication of notices commending or directing
attention to the professional skill, knowledge,
services or qualifications, or depreciating those of
others; or of being associated with such advertising
or publication, is contrary to public Interest and
discreditable to the profession.
The Board recognises that the profession has a duty
to disseminate information about advances in
pharmaceutical sciences and therapeutics provided it
is done in an ethical manner.

PART THREE: DISCIPLINARY JURISDICTION AND
PROCEDURE

1. DISCIPLINARY JURISDICTION OF THE BOARD

1.1 In Respect of Registered Pharmacists :
The Board may initiate disciplinary proceedings against
any registered pharmacist under the provisions of
subsection 17 (1) (a), (b) and (c) of the Act which
read:
If it comes to the knowledge of the Board that a
registered pharmacist-
(a) has obtained registration by a fraudulent or
incorrect statement; or
(b) has been convicted of any offence (See
Appendix I on "Convictions in a court of
law") which, in the opinion of the Board,
renders him unfit to be on the register or of
any offence (see Appendix I on
"Convictions in a court of law") under the
this Act or under any written law in force in
Malaysia relating to poisons, dangerous
drugs or therapeutic substances; or
(c) has been guilty of infamous or disgraceful
conduct in a professional sense."

The Board may initiate disciplinary proceedings
against any registered body corporate under the
provisions of subsection 13(7):

"13 (7) If-
(a) a body corporate carrying on a business
which comprises the retail sale of poisons,

dangerous drugs or therapeutic substances
has been convicted of an offence under
this Act or under any written law relating to
poisons, dangerous drugs or therapeutic
substances in force; or
(b) any director or officer of or any other person
in the employment of any such body-
(i) has been convicted of an offence
under this Act or the aforesaid written
laws;
(ii) has been convicted of any other
criminal offence which in the opinion
of the Board renders him, or would if
he were a registered pharmacist
render him liable to any of the
punishments under section 18A; or
(iii) has been guilty of any misconduct
which, in the opinion of the Board,
renders him, or would if he were a
pharmacist render him;
the Board may inquire into the case and may, unless
the body corporate satisfies the Board that the act or
omission in question was not connived at or
instigated by their superintendent or by any of their
directors or managers, and that the person guilty
thereof is no longer in their employment, refuse to
register such body corporate or, in the case of a body
corporate already registered if it deems fit, impose
any of the punishments under section 18A.


1.2 In Respect of a Registered Body Corporate
Section 13(7) of the same Act,
If
(a) a body corporate carrying on a business
which comprises the retail sale of poisons,
dangerous drugs or therapeutic substances
has been convicted of an offence under this
Act or under any written law relating to
poisons, dangerous drugs or therapeutic
substances in force; or

(b) any director or officer of or other person in
the employment of any such body

(i) has been convicted of an offence under
this Act or the aforesaid written laws;

(ii) has been convicted of any other
criminal offence which in the opinion of
the Board renders him, or would if he
were a registered pharmacist render
him, liable to any of the punishments
under section 18A; or

(iii) has been guilty of any misconduct
which, in the opinion of the Board,
renders him, or would if he were a
registered pharmacist render him, liable
to any of the punishments under
section 18A;

the Board may inquire into the case and may,
unless the body corporate satisfies the Board that
the act or omission in question was not connived

at or instigated by their superintendent or by any of
their directors or managers, and that the person
guilty thereof is no longer in their employment,
refuse to register such body corporate or, in the
case of a body corporate already registered, if it
deems fit, impose any of the punishments under
section 18A

1.3 In Respect of Any Executor, Administrator
or Trustee of A Deceased Registered
Pharmacists Estate.

Section 14(1) states that -

Subject to this section, if a registered pharmacist
dies while carrying on a business which comprises
the retail sale of poisons, dangerous drugs or
therapeutic substances, any executor, administrator
or trustee of his estate who carries on the business
after his death in accordance with the conditions
hereinafter mentioned shall be entitled to use in
connection with the business such titles and
descriptions as might have been used by the
deceased registered pharmacist

However, Subsection (3) of the same section
cautioned that
If any such executor, administrator or trustee or
any person in his employment -
(a) has been convicted of an offence under this
Act or under any written law relating to the
therapeutic substances, or dangerous drugs
or poisons for the time being in force in
Malaysia; or

(b) has been convicted of any other criminal
offence, or been guilty of any misconduct,
which, in the opinion of the Board, renders
him, or would if he were a registered
pharmacist render him, liable to any of the
punishments under section 18A.

the Board may inquire into the case and may,
unless in the case of an act or omission by a
person in his employment, the executor,
administrator or trustee satisfies the Board that the
act or omission in question was not connived at or
instigated by him, direct that he shall cease to be
entitled to use any title or description which might
have been used by the deceased pharmacist
1.4. Definition Of Misconduct, Infamous Or
Disgraceful Conduct In A Professional
Sense
Disreputable behaviour, a breach of professional
responsibility or requirement identified in the Code
could form the basis of a complaint of professional
misconduct. The Board or its Committee of Inquiry
in considering whether or not action should follow,
may take into consideration the circumstances of
an individual case and do not regard themselves as
being limited to those matters which are mentioned
in the code only.
2. PROCEDURE OF INQUIRY
The Registration of Pharmacists Regulations 2004
provides the following procedures pertaining to
disciplinary inquiry : -


2.1 Complaints Against A Registered
Pharmacist and A Body Corporate
In accordance with Regulation 14;
(1) any person who seeks to make a complaint
against or submit an information of a registered
pharmacist or body corporate shall make the
complaint or submit the information to the Secretary
of the Board, who shall then refer that complaint or
information to the Board.
(2) Where the Board has received a complaint or
information under subregulation (1) and it is
satisfied that there may be sufficient grounds for
the complaint or information, it shall appoint a
Committee of Inquiry to investigate the complaint or
information.
2.2 Committee of Inquiry
(1) Every Committee of Inquiry shall comprise of
five fully registered pharmacists and each of them
having a valid annual certificate.
(2) The Board may at any time revoke the
appointment of any member of any Committee of
Inquiry or may remove any member of any
Committee of Inquiry or fill any vacancy in any
Committee of Inquiry.
(3) The Board shall nominate a member of a
Committee of Inquiry to be the Chairman of the
Committee of Inquiry.
(4) The quorum of a Committee of Inquiry shall be
three.


(5) The Chairman shall preside at all meetings of
the Committee of Inquiry.
(6) The decision of a Committee of Inquiry shall be
by a majority.
2.3 Investigation By The Committee Of Inquiry
In Accordance with Regulation 16;
(1) Prior to the commencement of the investigations
by the Committee of Inquiry, the Secretary of the
Board shall forward a notice by registered post to
the registered pharmacist or body corporate at his
or its last known address, which shall
(a) state the complaint against or information of
the registered pharmacist or body corporate;
(b) require the registered pharmacist or body
corporate to provide a written explanation
regarding the complaint or information to the
Committee of Inquiry within such period as
specified in the notice, but such period shall
not be less than fourteen days from the date
of the notice; and
(c) request the registered pharmacist or body
corporate to attend and give evidence before
the Committee of Inquiry, where required to
do so.
(2) the Committee of Inquiry shall, after the period
as specified in paragraph (1)(b), commence the
investigation of the complaint or information and
shall give the registered pharmacist or body
corporate reasonable opportunity to be heard, and
due consideration shall be given to any explanation
that may be given by the registered pharmacist or
body corporate.

(3) the Committee of Inquiry shall upon completion
of its investigation of the complaint or information,
submit a report together with its recommendation to
the Board for its consideration.
2.4 Summary Dismissal Of Complaint Or
Information
The Committee of Inquiry to which such complaint
or information has been forwarded, may
recommend to the Board to summarily dismiss any
complaint or information if the Committee of Inquiry
is satisfied
(a) that the name and address of the
complainant or informant is unknown or
untraceable;
(b) that even if the facts were true, the facts do
not constitute a matter provided under
subsection 13(7) or 17(1) of the Act; or
(c) for reasons which must be recorded, that
there is reason to doubt the truth of the
complaint or information.
2.5 Inquiry By The Board
(1) Upon receipt of a report from the Committee of
Inquiry and on its recommendation, the Board
shall, where it is satisfied that there are grounds for
the complaint or information against the registered
pharmacist or body corporate


(a) cause a charge containing the facts of the
complaint or information alleged to have
been committed by the registered
pharmacist or body corporate to be
forwarded by registered post to him or it at
his or its last known address;
(b) request the registered pharmacist or body
corporate to attend the inquiry to be
convened by the Board in pursuant of
subsection 13(7) or 17(1) of the Act; and
(c) inform the registered pharmacist or body
corporate that an opportunity to be heard
may be given to him or it, where
(i) in the case of the body corporate, it may
be heard by a representative appointed
in writing or by counsel;
(ii) in the case of any director, officer or
other person in the employment of the
body corporate, he may be heard either
personally or by counsel; or

(iii) in the case of a registered pharmacist,
he may be heard either personally or by
counsel.

(2) Where the registered pharmacist or body
corporate, without reasonable excuse, fails to
attend the inquiry convened by the Board, the
Board may proceed to hear the case
notwithstanding the absence of registered
pharmacist or body corporate, if the Board is
satisfied that provisions; of subregulation (1) have
been complied with.

(3) The Board may regulate its own procedure in
such a manner as it deems fit.
2.6 Appointment and Payment of Legal Advisor
(1) The Board or Committee of Inquiry may appoint
a legal adviser to assist the Board or Committee of
Inquiry during any inquiry.
(2) The Board or Committee of Inquiry may appoint
any person who is and has been advocate and
solicitor for a period of not less than five years to
advise it on
(a) all questions of law ensuing in the
course of the inquiry; and
(b) the meaning and construction of all
documents produced during the
inquiry.
(3) The legal adviser is entitled to be paid such fees
as are from time to time fixed by the Board.
2.7 Members Who Are Disqualified From Any
Meeting Of The Board Inquiring Into Any
Disciplinary Matter
No member of the Board or Committee of Inquiry
shall attend or participate in any meeting of the
Board or Committee of Inquiry inquiring into any
disciplinary matter if
(a) he is the complainant; or
(b) he is personally acquainted with any
relevant fact.

3. PUNISHMENTS
In accordance with Section 18(A) of the Act,
Subsection (1), the Board may, at conclusion of an
inquiry under section 13(7) or section 17(1), impose
any of the following punishments;
(a) order the name of the registered pharmacist
or body corporate to be removed from the
register;
(b) order the name of the registered pharmacist
or body corporate to be suspended from the
register for such period as it may think fit; or
(c) order the registered pharmacist or body
corporate to be reprimanded.
Subsection (2) the Board may also, at conclusion of
the inquiry mentioned in subsection (1)-
(a) order the registered pharmacist or body
corporate to pay costs to the Board or
complainant where an order under any of
the paragraphs in subsection (1) is made;
(b) order the complainant to pay costs to the
registered pharmacist or body corporate
where no case has been made out against
the registered pharmacist or body
corporate,
and such cost may be recovered as a civil debt.
4. APPEAL
In accordance with Section 19 of the said Act, any
person or body corporate aggrieved by any
punishments imposed by the Board under Section
18A, or by any refusal or failure to enter his or its
name in the register, or by any refusal to issue to
him or to it an annual certificate, may appeal to the
Minister whose decision shall be final.

APPENDIX I
CONVICTIONS IN A COURT OF LAW

In considering convictions the Board is bound to
accept the determination of any court of law as
conclusive evidence that the person was guilty of the
offence of which he was convicted. Persons who face
a charge should be mindful of this before they choose
to plead guilty to the charge, or renounce appeal
against conviction merely to avoid publicity or a
heavier sentence. It is not open to a person who had
been convicted of an offence to plead before the
Board that he was in fact innocent. It is therefore
unwise for a person to plead guilty in a court of law to
a charge to which he believes that he has a defence.


APPENDIX II
DUTIES AND RESPONSIBILITIES OF A SUPERINTENDENT

The provisions of Section 13 of the Act requires the
business of a body corporate pertaining to the
keeping, retailing, dispensing and compounding of
poisons, dangerous drugs or therapeutic substances,
to be under the control and management of a
superintendent who is a registered pharmacist. It is
legitimate to conclude that this statutory requirement
exists to preserve the sanctity of professionalism in a
retail pharmacy and to assure a reasonable standard
of pharmaceutical services in such business.
It is therefore necessary to determine, and for the
parties involved to know, the scope of jurisdiction a
superintendent has in the running of a retail business.
After deliberation on the various aspects of the retail
business, the Board is of the opinion that the
superintendent has sole authority over the following
matters:
(1) The nature, quality and adequacy of amount of
goods and services of all kinds reasonably necessary
to enable an adequate pharmaceutical service to be
provided, and choice of the supplier of such goods
and services.
(2) In relation to the pharmaceutical service
(a) the control of staff and the allocation of duties
to individual members;
(b) the observance of all legal and professional
requirements including the ordering, purchase,
sale, supply, import, export, storage, labelling,
manufacturing, mixing, compounding and
dispensing of dangerous drugs, poisons and
therapeutic substances;

(c) the condition of the pharmacy.
(3) The settlement of all questions concerning the
nature and extent of the pharmaceutical service or
which involve in any way pharmaceutical knowledge
or professional conduct.
The term pharmaceutical service means the
furnishing of poisons, dangerous drugs, therapeutic
substances and related diagnostic, medical and
surgical products and appliances, whether on
prescription or otherwise, and information and advice
connected therewith.

Pharmacy Management

Uploaded by

Copyright:

Available Formats

Pharmacy Management

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Pharmacy Management

Uploaded by

Copyright:

Available Formats

Pharmacy Board Malaysia 2009 1

CODE OF CONDUCT FOR PHARMACISTS AND BODIES

You might also like